Large granular lymphocytic (LGL) leukemia is a kind of cancer that affects blood cells. The disease is rare: Only about 1,000 people per year are diagnosed with it. It affects men and women in roughly ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
An international study coordinated by a University of Helsinki research group demonstrates that the body's immune system attacks itself in a rare type of blood cancer. Consequently, treatment should ...
ORLANDO, Fla.--(BUSINESS WIRE)--The LGL Group, Inc. (“LGL” or “the Company”) announced today that its Board of Directors (“BOD”) has approved a spin-off of the MTronPTI subsidiary. The Company had ...
Total revenues increased $162,000 to $1,157,000 for the three months ended December 31, 2024 from $995,000 for the three months ended December 31, 2023 Income from continuing operations before income ...
The LGL Group, Inc. (NYSE American:LGL), a manufacturer of electronic components with an impressive 76.1% gross profit margin and "GOOD" financial health rating according to InvestingPro, has ...
Mtron common stock trades on the NYSE American under the symbol “MPTI.” The pro-forma shares outstanding for MPTI post the spin-off are 2.67 million. The pro-forma shares outstanding for LGL post spin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback